• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers.新型冠状病毒肺炎对美国国立癌症研究所指定的综合癌症中心开展的癌症临床试验的影响。
J Immunother Precis Oncol. 2021 May;4(2):56-63. doi: 10.36401/jipo-20-30. Epub 2020 Nov 13.
2
Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers.在国家癌症研究所指定癌症中心，COVID-19 大流行期间癌症治疗试验的入组模式。
Cancer J. 2022;28(2):111-117. doi: 10.1097/PPO.0000000000000578.
3
A National Map of NCI-Designated Cancer Center Catchment Areas on the 50th Anniversary of the Cancer Centers Program.美国国立癌症研究所指定癌症中心服务区的全国地图：纪念癌症中心计划 50 周年。
Cancer Epidemiol Biomarkers Prev. 2022 May 4;31(5):965-971. doi: 10.1158/1055-9965.EPI-21-1230.
4
Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute-Designated Cancer Program.在一个非国立癌症研究所指定的癌症项目中，基于二代测序结果进行基因组改变的临床试验入组目标。
J Oncol Pract. 2016 Apr;12(4):e396-404. doi: 10.1200/JOP.2015.008433. Epub 2016 Feb 23.
5
The role of National Cancer Institute-designated cancer center status: observed variation in surgical care depends on the level of evidence.美国国家癌症研究所指定癌症中心地位的作用：观察到的手术护理差异取决于证据水平。
Ann Surg. 2012 May;255(5):890-5. doi: 10.1097/SLA.0b013e31824deae6.
6
Access to Accredited Cancer Hospitals Within Federal Exchange Plans Under the Affordable Care Act.根据《平价医疗法案》，联邦医保交易所计划下的参保人能否使用经认可的癌症医院服务。
J Clin Oncol. 2017 Feb 20;35(6):645-651. doi: 10.1200/JCO.2016.69.9835. Epub 2017 Jan 9.
7
The Impact of the COVID-19 Pandemic on Tobacco Treatment Program Implementation at National Cancer Institute-Designated Cancer Centers.COVID-19 大流行对美国国家癌症研究所指定癌症中心烟草治疗项目实施的影响。
Nicotine Tob Res. 2023 Jan 5;25(2):345-349. doi: 10.1093/ntr/ntac160.
8
The Prevalence of Dissemination and Implementation Research and Training Grants at National Cancer Institute-Designated Cancer Centers.国家癌症研究所指定癌症中心的传播和实施研究及培训补助金的流行情况。
JNCI Cancer Spectr. 2021 Dec 15;6(1). doi: 10.1093/jncics/pkab092. eCollection 2022 Feb.
9
Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.调查在 NCI 指定的综合性癌症中心临床试验资格和入组方面的潜在差异。
Cancer Med. 2023 Jun;12(11):12802-12812. doi: 10.1002/cam4.5933. Epub 2023 May 7.
10
Enrollment of patients with lung and colorectal cancers onto clinical trials.招募肺癌和结直肠癌患者参加临床试验。
J Oncol Pract. 2013 Mar;9(2):e40-7. doi: 10.1200/JOP.2012.000598.

引用本文的文献

1
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.一项两阶段2期、多中心、随机、双盲、安慰剂对照研究，旨在评估Ec-18改变头颈部鳞状细胞癌放化疗继发口腔黏膜炎严重程度和病程的安全性和有效性。
Cancers (Basel). 2025 May 14;17(10):1663. doi: 10.3390/cancers17101663.
2
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high -expressing normal lung.肺癌与新型冠状病毒肺炎的共病：免疫调节基因转录本在高表达正常肺组织中的作用
Ther Adv Med Oncol. 2022 Oct 28;14:17588359221133893. doi: 10.1177/17588359221133893. eCollection 2022.
3
The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research.COVID-19 大流行作为创新的催化剂：评估临床研究中适合目的创新方法的监管框架。
Trials. 2022 Sep 30;23(1):833. doi: 10.1186/s13063-022-06707-w.
4
COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining.COVID-19大流行与癌症临床试验的混乱局面：寻找一线希望。
J Immunother Precis Oncol. 2020 Nov 16;4(2):64-66. doi: 10.36401/JIPO-20-X7. eCollection 2021 May.
5
The immune system, cancer, and pathogens: It takes three to tango!免疫系统、癌症与病原体：三者共舞！
J Immunother Precis Oncol. 2021 May 14;4(2):33-34. doi: 10.36401/JIPO-21-X1. eCollection 2021 May.
6
Patterns of Enrollment in Cancer Treatment Trials During the COVID-19 Pandemic at National Cancer Institute-Designated Cancer Centers.在国家癌症研究所指定癌症中心，COVID-19 大流行期间癌症治疗试验的入组模式。
Cancer J. 2022;28(2):111-117. doi: 10.1097/PPO.0000000000000578.

本文引用的文献

1
Rethinking cancer clinical trials for COVID-19 and beyond.重新思考癌症临床试验在 COVID-19 及以后的应用。
Nat Cancer. 2020 Jun;1(6):568-572. doi: 10.1038/s43018-020-0083-x.
2
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials.新型冠状病毒病 2019（COVID-19）疫情与癌症临床试验入组的相关性。
JAMA Netw Open. 2020 Jun 1;3(6):e2010651. doi: 10.1001/jamanetworkopen.2020.10651.
3
Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.COVID-19 对肿瘤学临床试验开展的早期影响及长期变革机遇：美国临床肿瘤学会调查研究结果。
JCO Oncol Pract. 2020 Jul;16(7):417-421. doi: 10.1200/OP.20.00275. Epub 2020 May 12.
4
COVID-19 exacerbating inequalities in the US.新冠疫情加剧美国的不平等现象。
Lancet. 2020 Apr 18;395(10232):1243-1244. doi: 10.1016/S0140-6736(20)30893-X.
5
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.扩大入选标准以使临床试验更具代表性：美国临床肿瘤学会与癌症研究之友联合研究声明
J Clin Oncol. 2017 Nov 20;35(33):3737-3744. doi: 10.1200/JCO.2017.73.7916. Epub 2017 Oct 2.
6
The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.临床试验参与在癌症研究中的作用：障碍、证据与策略
Am Soc Clin Oncol Educ Book. 2016;35:185-98. doi: 10.1200/EDBK_156686.

The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers.

作者信息

Gupta Diviya, Kato Shumei, Kurzrock Razelle

机构信息

School of Medicine, University of California San Diego, La Jolla, CA, USA.

Center for Personalized Cancer Therapy and Division of Hematology/Oncology, University of California San Diego Moores Cancer Center, La Jolla, CA, USA.

出版信息

J Immunother Precis Oncol. 2021 May;4(2):56-63. doi: 10.36401/jipo-20-30. Epub 2020 Nov 13.

DOI:10.36401/jipo-20-30
PMID:34337550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8320380/
Abstract
摘要